Fundamental Analysis
44 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +56.3% | -17.0% | 1 / 3 | +7.4% | +4.24 pp | +1.25 pp | +3.4% | 0.50 | 21.45 | 196 | +7,4% | 7,8 | +56,3% | 21.45 | 11.51 | +86,4% |
| Pts | 8 | 0 | 4 | 0 | 12 | 8 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 7.700 (close price on 2026-10-19)EPS (TTM): 358,9
Financial charts
1.Revenue & growth
VND bn196Q2/26
1.Revenue & growth
VND bn196Q2/26
2.Profit & growth
VND bn7,84Q2/26
3.Profit mix (Penman)
VND bn20,1Q2/26
4.Margins & cost structure
%19.3%Q2/26
5.Returns & cash cycle
% · days3.7%Q2/26
6.Earnings quality & cash
VND bn75,6Q2/26
7.Asset structure
VND bn908Q2/26
8.Funding & debt health
VND bn · times908Q2/26
9.Revenue backlog
VND bn10,2Q2/26
10.Valuation
times · %21,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %176Q2/26
Adjusted EPS growth, latest quarter
56.8%
Average adjusted EPS growth, 3 quarters
-16.9%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26